SCHEMBL6692082

SCHEMBL6692082

COc1cc2ncnc(Nc3ccc(CC=O)cc3)c2cc1OCCCN1CCOCC1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 7/20 0.79
EGFR P00533 11/20 0.73
KDR P35968 9/20 0.71
AURKA O14965 3/20 0.71
LCK P06239 2/20 0.71
RET P07949 2/20 0.71
MET P08581 2/20 0.71
MAPT P10636 2/20 0.71
LTK P29376 2/20 0.71
TNK2 Q07912 2/20 0.71
MAP4K5 Q9Y4K4 2/20 0.71
ROCK2 O75116 1/20 0.71
ALDH1A1 P00352 1/20 0.71
FYN P06241 1/20 0.71
PDGFRA P16234 1/20 0.71
TTK P33981 1/20 0.71
MAP2K2 P36507 1/20 0.71
MAP2K1 Q02750 1/20 0.71
BTK Q06187 1/20 0.71
TYRO3 Q06418 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531151 0.89 SRC (0.86) SRCEGFRKDRAURKALCK
SCHEMBL28424819 0.88 SRC (0.85) SRCEGFRKDRAURKALCK
SCHEMBL13529060 0.88 SRC (0.84) SRCEGFRKDRAURKALCK
SCHEMBL6704281 0.86 EGFR (0.80) SRCEGFRKDRAURKALCK
Hydrochloric Acid SCHEMBL3535974 0.86 EGFR (0.80) SRCEGFRKDRAURKALCK
SCHEMBL19154598 0.85 SRC (0.80) SRCEGFRKDRAURKALCK
SCHEMBL12694312 0.85 EGFR (0.79) SRCEGFRKDRAURKALCK
SCHEMBL5866417 0.85 EGFR (0.75) SRCEGFRKDRAURKALCK
SCHEMBL5866422 0.85 EGFR (0.75) SRCEGFRKDRAURKALCK
SCHEMBL22383954 0.84 EGFR (0.86) SRCEGFRKDRLCKRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069145-A2 ANTICANCER COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-08-19 WO disclosed